Literature DB >> 27138191

Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.

Jing Ding1, Cong Li1, Jie Tang1, Cheng Yi1, Ji-Yan Liu1, Meng Qiu2.   

Abstract

Preexisting type 2 diabetes mellitus (preDM) increases occurrence and mortality of colorectal cancer (CRC). Insulin growth factor (IGF)/insulin receptor (IR) axes play an important role in the development of both diabetes and CRC. We aimed to explore the characteristics of proteins expression in IGF/IR axes in CRC tissues with preDM. Two hundred fifty CRC patients in West China hospital were included in analysis. Among them, 125 patients had history of diabetes matched by 125 CRC without diabetes at a 1:1 ratio. Immunohistochemical staining was used to detect the expression of proteins in IGF/IR axis. More positive expression of IGF-1, IGF-1R and IR were found in CRC group with diabetes than in non-diabetes group. No difference was detected in the expression of IR substrate-1, IR substrate-2, IGF-2, IGF binding protein 3, and mammalian target of rapamycin between two groups. Multivariate analysis showed that diabetes history was associated with all of the expression of IGF-1, IGF-1R and IR, and higher T staging and lymph node metastasis were respectively independent factors of IGF-1 and IGF-1R expression in CRC patients. Besides, IGF-1 expression was positively associated with IGF-1R and IR expression in all CRC tissues, and the association of IGF-1 and IR expression seemed to be closer in diabetes group than in non-diabetes group. Higher expression of IGF-1, IGF-1R and IR proteins in CRC was associated with diabetes, suggesting IGF-1/IR signaling may play a special part in development of CRC in patients with diabetes.

Entities:  

Keywords:  Colorectal cancer; Diabetes mellitus; Insulin receptor; Insulin-like growth factor; Insulin-like growth factor receptor

Mesh:

Substances:

Year:  2016        PMID: 27138191     DOI: 10.1007/s12253-016-0065-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  29 in total

1.  Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer.

Authors:  Kuo-Hsing Chen; Yu-Yun Shao; Zhong-Zhe Lin; Yi-Chun Yeh; Wen-Yi Shau; Raymond Nienchen Kuo; Ho-Min Chen; Chiu-Ling Lai; Kun-Huei Yeh; Ann-Lii Cheng; Mei-Shu Lai
Journal:  Oncologist       Date:  2014-07-24

Review 2.  Diabetes and cancer: epidemiology and potential mechanisms.

Authors:  Hans-Georg Joost
Journal:  Diab Vasc Dis Res       Date:  2014-09-29       Impact factor: 3.291

3.  mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.

Authors:  Rui Liu; Li-Ling Hu; Ao Sun; Ya-Jing Cao; Tao Tang; Xi-Peng Zhang; Qing-Huai Zhang
Journal:  Arch Med Res       Date:  2014-04-18       Impact factor: 2.235

4.  Expression of insulin-like growth factor-1 receptor in human colorectal cancer.

Authors:  A Hakam; T J Yeatman; L Lu; L Mora; G Marcet; S V Nicosia; R C Karl; D Coppola
Journal:  Hum Pathol       Date:  1999-10       Impact factor: 3.466

5.  Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.

Authors:  Amikar Sehdev; Ya-Chen T Shih; Benjamin Vekhter; Marc B Bissonnette; Olufunmilayo I Olopade; Blase N Polite
Journal:  Cancer       Date:  2014-11-25       Impact factor: 6.860

6.  Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer.

Authors:  Ichitarou Shiratsuchi; Yoshito Akagi; Akihiko Kawahara; Tetsushi Kinugasa; Kansakar Romeo; Takefumi Yoshida; Yasuhiko Ryu; Yukito Gotanda; Masayoshi Kage; Kazuo Shirouzu
Journal:  Anticancer Res       Date:  2011-07       Impact factor: 2.480

Review 7.  The proliferating role of insulin and insulin-like growth factors in cancer.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Trends Endocrinol Metab       Date:  2010-07-19       Impact factor: 12.015

8.  Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation.

Authors:  H Zhang; D H Fagan; X Zeng; K T Freeman; D Sachdev; D Yee
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

9.  Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.

Authors:  Sabina Rinaldi; Rebecca Cleveland; Teresa Norat; Carine Biessy; Sabine Rohrmann; Jakob Linseisen; Heiner Boeing; Tobias Pischon; Salvatore Panico; Claudia Agnoli; Domenico Palli; Rosario Tumino; Paolo Vineis; Petra H M Peeters; Carla H van Gils; Bas H Bueno-de-Mesquita; Alina Vrieling; Naomi E Allen; Andrew Roddam; Sheila Bingham; Kay-Tee Khaw; Jonas Manjer; Signe Borgquist; Vanessa Dumeaux; Inger Torhild Gram; Eiliv Lund; Antonia Trichopoulou; Georgios Makrygiannis; Vassiliki Benetou; Esther Molina; Ignacio Donate Suárez; Aurelio Barricarte Gurrea; Carlos A Gonzalez; Maria-Jose Tormo; Jone M Altzibar; Anja Olsen; Anne Tjonneland; Henning Grønbaek; Kim Overvad; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Sophie Morois; Nadia Slimani; Paolo Boffetta; Mazda Jenab; Elio Riboli; Rudolf Kaaks
Journal:  Int J Cancer       Date:  2010-04-01       Impact factor: 7.396

Review 10.  Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.

Authors:  Zu-Bing Mei; Zhi-Jiang Zhang; Chen-Ying Liu; Yun Liu; Ang Cui; Zhong-Lin Liang; Guang-Hui Wang; Long Cui
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more
  5 in total

1.  Type 2 Diabetic Mellitus Is a Risk Factor for Nasopharyngeal Carcinoma: A 1:2 Matched Case-Control Study.

Authors:  Xing-Si Peng; Guo-Feng Xie; Wen-Ze Qiu; Yun-Hong Tian; Wei-Jun Zhang; Ka-Jia Cao
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

2.  The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies.

Authors:  Bo Zhu; Xiaomei Wu; Bo Wu; Dan Pei; Lu Zhang; Lixuan Wei
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

Review 3.  Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer.

Authors:  Baoqing Chen; Junyan Li; Dongmei Chi; Iman Sahnoune; Steliana Calin; Leonard Girnita; George A Calin
Journal:  Cells       Date:  2019-12-14       Impact factor: 6.600

4.  Survival Risk Analysis of Small Cell Lung Cancer Patients with Pre-Existing Type 2 Diabetes Mellitus: A Single-Center Retrospective Cohort Study.

Authors:  Jing Ding; Xudong Li; Jun Ge; Yuanqian Gong; Ya Zhou; Juan Xiao; Qin Yang; Jing Chen; Mian Mao
Journal:  Cancer Manag Res       Date:  2022-03-30       Impact factor: 3.989

Review 5.  Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.

Authors:  Aldona Kasprzak; Agnieszka Adamek
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.